Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jan Feder"'
Autor:
Christian Möhring, Jan Feder, Raphael U. Mohr, Farsaneh Sadeghlar, Alexandra Bartels, Robert Mahn, Taotao Zhou, Milka Marinova, Georg Feldmann, Peter Brossart, Martin von Websky, Hanno Matthaei, Steffen Manekeller, Tim Glowka, Jörg C. Kalff, Tobias J. Weismüller, Christian P. Strassburg, Maria A. Gonzalez-Carmona
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivePrognosis of patients with irresectable cholangiocarcinoma is still poor. The ABC-02 trial established the current first line (1L) standard systemic chemotherapy (CT) with gemcitabine/platinum derivate for advanced cholangiocarcinoma. Howeve
Externí odkaz:
https://doaj.org/article/3a0b0c8729054bd493c1b136c9000bca
Autor:
Martin W. von Websky, Peter Brossart, Jörg C. Kalff, Farsaneh Sadeghlar, Raphael Mohr, Christian Möhring, Hanno Matthaei, Tim R. Glowka, Christian P. Strassburg, Maria A. Gonzalez-Carmona, Jan Feder, Milka Marinova, Robert Mahn, Georg Feldmann, Steffen Manekeller, Alexandra Bartels, Tobias J. Weismüller, Taotao Zhou
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectivePrognosis of patients with irresectable cholangiocarcinoma is still poor. The ABC-02 trial established the current first line (1L) standard systemic chemotherapy (CT) with gemcitabine/platinum derivate for advanced cholangiocarcinoma. Howeve
Autor:
Brittany Balint, Jan Federspiel, Catherine Kollmann, Paul Teping, Tanja Schwab, Hans-Joachim Schäfers
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract We sought to determine whether there are differences in transforming growth factor-beta (TGFß) signaling in aneurysms associated with bicuspid (BAV) and unicuspid (UAV) aortic valves versus normal aortic valves. Ascending aortic aneurysms a
Externí odkaz:
https://doaj.org/article/47f71193a2cf4f14933a95c1282df93a
Autor:
Yong Kim, Phillip J. Restle, Doug Malone, David Shan, R. Groves, Eric Lai, David Hogenmiller, Jason D. Hibbeler, Christos Vezyrtzis, T.J. Bucelot, Jan Feder, Michael Koch
Publikováno v:
VLSIC
The IBM z13TM microprocessor utilizes a large resonant “mega-mesh” global clock distribution saving 50% of the final-stage clock mesh power and 8% of the total chip power in the desired frequency range of 4.5 to 5.5 GHz compared to a simulated, n